Partners HealthCare has won a $12 million grant from the National Institutes of Health to establish an innovation center in Boston to speed new health solutions to market. The grant will also enable HMS to educate researchers throughout the region on best practices in the field of medical commercialization. Anne Klibanski, the Laurie Carrol Guthart Professor of Medicine and associate dean for clinical and translational research at Harvard Catalyst, is quoted.
Cancers, long defined primarily by where they arose (breast, lung, blood cells, brain) are proving to be as individual as faces: increasingly defined, scientists are discovering, by their unique genetic and molecular makeup. Research by Levi Garraway, HMS associate professor of medicine and George Demetri, HMS professor of medicine, both of Dana-Farber Cancer Institute, is featured.
The Harvard Campaign, officially launched on September 21 after the quietest of quiet phases, seeks $6.5 billion—the largest initial target ever set in American higher education—and begins its public phase with $2.8 billion already received or pledged. Peter Sorger, the Krayer professor of systems pharmacology at HMS and head of the Harvard Program in Therapeutic Science, is quoted.
In a monthly column for PBS NewsHour, Dr. Howard Markel revisits moments that changed the course of modern medicine on their anniversaries, like the groundbreaking use of anesthesia on a surgical patient on Oct. 16, 1846 at Massachusetts General Hospital. Research conducted at HMS in the 1800s is cited.
Betsy Nabel, president of Brigham and Women’s Hospital and an HMS professor of medicine, authored this opinion piece in today’s Boston Globe about the effect of the federal shutdown on biomedical research.
It’s no secret that exercise is not just good for your body, but also the mind. Now, scientists have pinpointed why working out holds these brain benefits. Bruce Spiegelman, the Stanley J. Korsmeyer Professor of Cell Biology and Medicine at the Dana-Farber Cancer Institute, is one of the researchers.
Secretary of State John Kerry’s relationship with Vietnam is well known. This article provides coverage of Vanessa Kerry, HMS instructor in medicine at Massachusetts General Hospital, and her global health initiatives.
Once a niche treatment for people suffering from hormonal deficiencies caused by medical problems like endocrine tumors or the disruptive effects of chemotherapy, prescription testosterone gels are increasingly being sold as lifestyle products, to raise dipping levels of the male sex hormone as men age. Joel Finkelstein, HMS associate professor of medicine at Massachusetts General Hospital, is quoted.
A popular sports supplement sold as a workout booster to help users “train beyond” their limits contains a banned substance derived from methamphetamine, according to tests conducted by researchers from HMS and elsewhere. Pieter Cohen, HMS assistant professor of medicine at Cambridge Health Alliance, is one of the leaders of the study.
